drugset / Trial / NCT01358695
Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet
RandomizedFactorialQuadruple-blindTreatment
Summary
The purpose of this study is to provide evidence of the safety, tolerance, and efficacy of ANT-1207 in the treatment of Crow's Feet.
Timeline
- Start
- 2011-05
- Primary completion
- 2012-02
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | — | — |